Philadelphia-based Endo sold its international pharma unit to Knight Therapeutics this week for up to $99 million, while Ireland-headquartered Mallinckrodt sold Therakos, a specialist in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback